Greg Meyers, Bristol Myers Squibb chief digital and technology officer
September 23, 2024 10:00 AM EDT
People
R&D
AI

Q&A: Bris­tol My­ers’ tech chief on the promis­es and per­ils of AI bio

Andrew Dunn

Senior Biopharma Correspondent

For AI-fo­cused star­tups seek­ing out phar­ma deals, they have to go through peo­ple like Greg Mey­ers, the chief dig­i­tal and tech­nol­o­gy of­fi­cer at Bris­tol My­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

As­traZeneca, Dai­ichi’s TROP2 drug miss­es over­all sur­vival goal in Phase 3 breast can­cer tri­al

Reg­u­la­to­ry RNA start­up CAMP4 files for IPO as more biotechs line up list­ings

Ideaya out­lines reg­u­la­to­ry path for rare eye can­cer drug af­ter pos­i­tive mid-stage da­ta

A VC-backed ge­net­ic test­ing start­up to 'con­sid­er' mak­ing an of­fer to buy 23andMe

UK vac­cine start­up Vice­bio snags $100M to take on GSK, Pfiz­er and Mod­er­na

sponsored

PD­Cs vs. AD­Cs: A New Fron­tier in Tar­get­ed Can­cer Ther­a­pies and the Po­ten­tial for De­vel­op­ment Part­ner­ships

A service from the Financial Times